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Recent observations demonstrated that interleukin-1b
converting enzyme family proteases, now referred to
as caspase family, play central roles in apoptosis, or
programmed cell death. In this study, we tried to isolate
and characterize epidermal caspases. By DEAE-Sephacel
anion-exchange chromatography, human cornified cell
extract showed two caspase-like fractions (F-I and F-II)
with different substrate specificities. These were further
purified by Sephacryl S-200, Mono Q ion exchange and
Superose 6 gel chromatography. F-I showed a molecular
weight of 30 kDa and specifically hydrolyzed acetyl-
Asp-Glu-Val-Asp-methylcoumarinamide, a fluorogenic
substrate for caspase-3 (CPP32) with a Km value of
13.8 mM. F-I generated a characteristic 85 kDa fragment
from poly(ADP-ribose) polymerase. Inhibitor suscepti-
bility of F-I was very similar to that of caspase-3, further
confirming the caspase-3-like properties of F-I. In con-
Apoptosis, or programmed cell death, plays important rolesin various physiologic processes, such as developmentof organisms, tissue homeostasis, and recovery frompathologic disorders. Epidermis is one of the tissues inwhich apoptosis-like phenomena are often found. For
example, ‘‘sunburn cells’’ were frequently observed in UVB-irradiated
epidermis, in which nuclear condensation was a characteristic feature
of these cells (Young, 1987; Schwarz et al, 1995). Regression phase of
hair follicles (catagen) was thought to be an apoptotic process (Seiberg
et al, 1995; Lindner et al, 1997). Moreover, terminal differentiation of
keratinocytes is suggested to be an elaborative pathway of apoptosis
because it includes nuclear condensation and destruction of nuclei
(McCall and Cohen, 1991; Haake and Polakowska, 1993; Polakowska
et al, 1994). The molecular mechanism of epidermal apoptosis has not
been well understood, however.
Detailed studies on genetic pathways of programmed cell death in
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trast, the molecular weight of F-II was estimated to be
110 kDa, which was much higher than the other caspases.
F-II equally hydrolyzed acetyl-Asp-Glu-Val-Asp-methyl-
coumarinamide, and acetyl-Tyr-Val-Ala-Asp-methyl-
coumarinamide, caspase-1 (interleukin-1b converting
enzyme)-specific substrate, and was inhibited by acetyl-
Tyr-Val-Ala-Asp-aldehyde and acetyl-Tyr-Val-Ala-Asp-
aldehyde. Affinity labeling using biotinylated YVAD-cmk
demonstrated several positive bands ranging from 25 to
35 kDa, supporting the hypothesis that F-II is a complex
of multiple caspases. Reverse transcriptase-polymerase
chain reaction analysis demonstrated that among known
caspases tested, caspase-1, -2, -3, -4, and -7 were
expressed in cultured human keratinocytes. These results
suggest that multiple caspases are synthesized in human
keratinocytes and are involved in terminal differentiation.
Key words: apoptosis/cysteine protease/keratinocytes. J Invest
Dermatol 111:367–372, 1998
nematode C. elegance demonstrated that ced-3 was essential for the
execution of the cell death program (Yuan and Holvitz, 1990). Cloning
of ced-3 gene showed significant sequence homology to the mammalian
cysteine protease, interleukin 1-β converting enzyme (ICE) (Yuan et al,
1993). In addition, over-expression of ICE was found to induce
apoptotic cell death in rat fibroblasts (Miura et al, 1993). The fact that
inhibition of ICE activity by a potent ICE inhibitor, cytokine response
modifier A (CrmA) from cowpox virus (Ray et al, 1992), prevented
apoptosis in various cells (Miura et al, 1993; Gagliardini et al, 1994;
Tewari and Dixit, 1995a) further supported critical roles of ICE in
higher organisms. A number of attempts to hunt for enzymes similar
to ICE have been reported elsewhere, and 10 human ICE-related
genes have been cloned until recently. Such ICE-like proteases were
classified as ICE/ced-3 family, which was recently named caspase
family (Alnemri et al, 1996).
On the other hand, very limited reports were available for the
purification of active caspases from cells and tissues. Active caspase-1
(ICE) has been purified from human monocyte THP.1 cells (Thornberry
et al, 1992; Miller et al, 1993). Caspase-3 (CPP32/YAMA/apopain),
which was identified as one of the ICE homologs (Fernandes-Alnemri
et al, 1994; Tewari et al, 1995b), has been purified from THP.1 cells
as a protein responsible for cleavage of poly(ADP-ribose) polymerase
(PARP) during apoptosis (Nicholson et al, 1995). And also, Pai et al
have partially purified two distinct types of proteases that cleave sterol-
regulatory element binding protein (SREBP) from hamster liver.
Peptide sequence analysis revealed that they were identical to caspase-
3 and caspase-7 (Mch3/ICE-LAP3/CMH-1), respectively (Pai et al,
1996).
In this study, we tried to investigate participation of caspase-like
proteases in keratinocyte differentiation. The involvement of caspases
368 TAKAHASHI ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 1. Two distinct fractions were obtained
from DEAE-Sephacel anion-exchange chro-
matography. Human cornified cell extract was
applied to a DEAE-Sephacel column (2.5 cm320 cm)
and eluted with an increasing gradient of NaCl.
Caspase-like activities were measured using
fluorogenic substrates, Ac-YVAD-MCA and Ac-
DEVD-MCA, in each fraction. Two distinct fractions
(F-I and F-II) were obtained.
in proliferation and differentiation of keratinocytes is still being
debated. Here we describe the partial purification and biochemical
characterization of epidermal caspases. We successfully obtained two
distinct types of caspase-like proteases from normal human cornified
cell extract. These two fractions, which are referred to as F-I and F-
II, were quite different from each other in terms of molecular weight,
substrate specificity, and inhibitor susceptibility, yet both hydrolyzed
PARP with the cleavage product of 85 kDa fragment. Our results
suggest that multiple types of caspases participate in the epidermal
apoptosis and would be related to the terminal differentiation of
keratinocytes.
MATERIAL AND METHODS
Materials Synthetic fluorogenic tetrapeptide substrates [acetyl-Tyr-Val-Ala-
Asp-methylcoumarinamide (Ac-YVAD-MCA), acetyl-Asp-Glu-Val-Asp-
methylcoumarinamide (Ac-DEVD-MCA)], tetrapeptide inhibitors [acetyl-Tyl-
Val-Ala-Asp-aldehyde (Ac-YVAD-CHO), acetyl-Asp-Glu-Val-Asp-aldehyde
(Ac-DEVD-CHO)], and protease inhibitors (E-64 and pepstatin A) were
purchased from Peptide Institute (Osaka, Japan). Biotinyl-Tyl-Val-Ala-Asp-
chrolomethylketone (biotin-YVAD-cmk) was a product of Calbiochem (La
Jolla, CA). Protease inhibitors phenylmethylsulfonyl fluoride and N-ethylmalei-
mide were obtained from Wako Pure Chemicals (Tokyo, Japan). Tosyl-lysine
chloromethylketone, aprotinin, leupeptin, and antipain were from Boehringer
(Mannheim, Germany), and iodoacetic acid, soybean trypsin inhibitor were
from Sigma (St. Louis, MO). DEAE-Sephacel, Sephacryl S-200, FPLC Mono
Q, and Precision Column Superose 6 for SMART system were purchased from
Pharmacia (Uppsala, Sweden). All other chemicals were of reagent grade.
Assay of caspases Caspase activity was measured using fluorogenic substrates
Ac-YVAD-MCA or Ac-DEVD-MCA (Miller et al, 1993). Briefly, 50 µl of
samples were incubated at 37°C for 30 min with 50 µM of substrate in 150 µl
of 25 mM HEPES containing 10% sucrose, 0.1% 3-[(3-cholamidopropyl)
dimethylammonio] propane-sulfonic acid (CHAPS) and 1 mM dithiothreitol
(HSCD buffer). The reaction was stopped by adding 2 ml of 0.1 M chloroacetic
acid. Liberation of aminomethylcoumarin was measured by the fluorescence
intensity at 460 nm excited by 380 nm recorded on a FP-777 fluorophotometer
(JASCO, Tokyo, Japan). Inhibitor assays were performed similarly by adding
50 µl of inhibitor samples. Inhibitor susceptibility was estimated by the residual
caspase activity after incubation at 37°C for 30 min using phosphate-buffered
saline as a control.
Protein assay Protein concentration was determined by bicinchonic acid
(BCA) method with BCA Protein Assay Reagent (Pierce, Rockford, IO) using
bovine serum albumin as a standard.
Purification of caspase-like enzymes from cornified cells All purification
steps were carried out at 4°C. Human cornified cells (30 g) scraped from heels
of healthy volunteers (age 27–42) were homogenized in 0.1 M Tris-HCl,
pH 8.0 containing 0.14 M NaCl, 0.1% CHAPS, and 1 mM dithiothreitol with
a glass homogenizer (Wheaton, Millville, NJ). The resulting suspension was
extracted for 2 h. After centrifugation at 25,000 3 g for 15 min, the supernatant
was filtered with a bottle-top filter unit (0.22 µm) equipped with a glass fiber
prefilter. The filtrate was concentrated about 10-fold by ultrafiltration using
YM-10 membrane (Amicon, Beverly, MA) and dialyzed overnight against
20 mM Tris-HCl, pH 7.8 containing 10% sucrose, 0.1% CHAPS, and 1 mM
dithiothreitol (buffer A). The crude extract was applied to a DEAE-Sephacel
ion-exchange column (2.5 cm 3 20 cm), equilibrated with buffer A, and was
eluted with a two-step linear gradient of NaCl from 0 to 0.3 M and from
0.3 M to 1 M. Enzymatically active fractions were pooled, concentrated, and
applied onto a Sephacryl S-200 gel filtration column (1.6 3 90 cm) equilibrated
with phosphate-buffered saline containing 10% sucrose, 0.1% CHAPS, and
1 mM dithiothreitol (buffer B). The active fractions were concentrated to
2.5 ml and passed through a PD-10 column equilibrated with buffer A. The
enzyme fractions were applied onto a Mono Q fast protein liquid chromato-
graphy column and eluted with increasing NaCl concentration up to 0.5 M.
The enzyme fractions were collected and concentrated for further analysis.
Finally, caspase-like enzymes were further purified by Superose 6 gel filtration
using SMART system to determine their molecular weights using LMW Gel
Filtration Calibration Kit (Pharmacia) consisting of blue dextran (.2 3 106),
bovine serum albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A
(25 kDa), and ribonuclease A (13.7 kDa).
Kinetic studies Enzyme samples in HSCD buffer were incubated with
various concentrations of fluorogenic substrates. Initial rate v was calculated
from the increase of the liberated aminomethylcoumarin, and Michaelis constant
Km was determined by the plots of 1/[S] and 1/v (Lineweaver–Burk plots).
Inhibition constant Ki was determined from the plots of [I] and 1/v with
different substrate concentrations (Dixon plots).
Western blot analysis of PARP cleavage PARP was purified from bovine
thymus according to the method of Yoshihara et al (1978). Purified bovine
PARP was incubated with enzyme fractions in HSCD buffer for 30 min at 37°C.
Cleavage products were analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and subsequent western blotting. After SDS-
PAGE, proteins were transferred to a polyvinylidenefluoride membrane (Milli-
pore, Bedford, MA) at 2 mA per cm2 for 2 h. The membranes were immersed
in 3% skim milk (Snow Brand, Sapporo, Japan), and incubated with anti-PARP
antibody (Enzyme System Products, Dublin, CA), followed by horseradish
peroxidase conjugated anti-rabbit IgG. Enhanced Chemiluminescence (ECL)
Western Blotting Detection System (Amersham, Bucks, U.K.) was used for
detection. Molecular weight of the cleavage product was determined by
Prestained SDS-PAGE Standards (BioRad, Hercules, CA).
Affinity labeling and blotting Biotin-labeled YVAD-cmk was used as an
affinity ligand to detect caspase-like enzymes. The purified protease samples
were incubated with the biotin-YVAD-cmk for 30 min at room temperature,
and applied onto 12.5% SDS or native-PAGE gels under nonreducing condition.
After transfer to a polyvinylidenefluoride membrane, the enzyme-inhibitor
complexes were stained with horseradish peroxidase-conjugated streptavidin
(BioRad) and visualized using ECL detection system. Molecular weight was
estimated using Biotinylated SDS-PAGE Standards (BioRad).
Cell culture and reverse transcriptase-polymerase chain reaction (RT-
PCR) analysis Human keratinocytes (Kurabo, Osaka, Japan) were cultured
in a serum-free K-GM medium. Poly (A1) RNA were isolated from the
cultured keratinocytes at 50%, 80%, 100% confluency as well as 2 d after
confluency (namely 120%) using FastTrack mRNA Isolation Kit (Invitrogen,
San Diego, CA) according to the manufacturer’s instructions. For the synthesis
of oligo-dT-primed cDNA, 250 ng of poly (A1) RNA was reverse transcripted
using 200 Units of SuperScript II (Gibco/BRL, Gaithersburg, MD) primed by
500 ng of oligo-(dT)15 primers (Promega, Madison, WI), in a total volume of
20 µl. After 1 h incubation at 37°C, the reaction was stopped by heating at
95°C for 5 min, and 1 µl of reverse transcriptase products were used as templates
for each PCR reaction. The PCR primers of seven caspase family members
(caspase-1–7) were designed based on the published mRNA sequences: caspase-
1, 59-CTGCCCAAGTTTGAAGGA-39 and 59-TTTAATGTCCTGGGAAG-
39 (expected length 310 bp); caspase-2 (Ich-1), 59-ATGGCCGCTGA-
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CAGGGG-39 and 59-GAACAGAAACCGTGCAT-39 (1080 bp); caspase-3, 59-
ATACTCCTTCCATCAAATAG-39 and 59-AACATCACAAAACCATAATC-
39 (410 bp); caspase-4 (TX/ICH-2/ICErel-II), 59-GCTGTTTACAA-
GACCCACGTGG-39, and 59-GTGGCTTCCATTTTCAA-39 (285 bp); cas-
pase-5 (ICErel-III/TY), 59-TCTGTTTGCAAGATCCACGAGA-39 and 59-
TGTGGTTTCATTTTCAA-39 (279 bp); caspase-6 (Mch2), 59-ATGAGCT-
CGGCCTCGGG-39 and 59-TAGCCTCTATTAATTAA-39 (915 bp); caspase-
7, 59-ATGGCAGATGATAGGGC-39 and 59-GACCCATTGCTTCTCAGC-
39 (917 bp). PCR amplification was performed for 35 cycles (40 s at 94°C,
50 s at 50–55°C, 40 s at 72°C). PCR products were analyzed on 2% agarose
gel electrophoresis.
RESULTS
Two distinct types of caspases are obtained from cornified cell
extract Figure 1 shows an elution profile of DEAE-Sephacel
chromatography. Two active fractions of caspase-like enzymes were
eluted at µ0.25 and 0.30 M NaCl concentrations. These are designated
as F-I and F-II, respectively. F-I showed a hydrolytic activity on Ac-
DEVD-MCA, a substrate designed for caspase-3, but had little effect
on Ac-YVAD-MCA, a substrate for caspase-1. F-I was further purified
by Sephacryl S-200 gel column and FPLC Mono Q, respectively. By
Sephacryl S-200, F-I showed a DEVD-specific activity at a molecular
weight of 30 kDa, and by Mono Q chromatography at pH 7.8, F-I
was eluted at µ0.25 M NaCl (data not shown).
On the other hand, F-II hydrolyzed both Ac-DEVD-MCA and
Ac-YVAD-MCA to a similar extent. F-II from DEAE-Sephacel
chromatography was further purified by the same steps. When we
applied F-II to Sephacryl S-200 gel chromatography, caspase-like
activity eluted at much higher molecular weight than 30 kDa (data
not shown).
To determine the molecular weight of these enzyme fractions, we
used a SMART system equipped with a Superose 6 gel filtration
column. Figure 2 shows the elution profiles of F-I and F-II by
Superose 6 chromatography, respectively. F-I showed a sharp and
single peak at a molecular weight of 30 kDa (Fig 2A). Molecular
weight of F-II was estimated to be µ110 kDa (Fig 2B), which was
much higher than those of caspase family members. F-II demonstrated
hydrolytic activities on both Ac-YVAD-MCA and Ac-DEVD-MCA
substrates.
Kinetic properties We used partially purified F-I and F-II from
the Mono Q step as samples for biochemical and enzymologic
characterization. Kinetic constants were determined for F-I and F-II
using tetrapeptide substrates with a continuous fluorometric assay as
shown in Table I. Cleavage activity of Ac-DEVD-MCA by F-I
showed Michaelis–Menten kinetics with a Km value of 13.8 µM. F-I
did not show any detectable activity on Ac-YVAD-MCA in this assay
condition. The Ki value against Ac-DEVD-CHO is 0.0389 nM, which
means that Ac-DEVD-CHO is a very specific inhibitor for F-I. F-II
demonstrated different kinetic properties from the known caspases.
Although it cleaved both tetrapeptide substrates, Km values for Ac-
DEVD-MCA and Ac-YVAD-MCA were 402 µM and 1029 µM,
respectively, which were considerably higher than the values of F-I.
The Ki value against Ac-YVAD-MCA was 8.19 µM, which shows
that Ac-YVAD-CHO is a relatively weak inhibitor for F-II.
Inhibitor susceptibility Table II summarizes the result of inhibitor
susceptibility for F-I and F-II. F-I was inhibited by thiol-alkylating
reagents, N-ethylmaleimide and iodoacetic acid. On the other hand,
E-64, which was also a universal cysteine protease inhibitor, did not
show any effect on F-I. Other serine, aspartic, and metallo-protease
inhibitors had no effect on F-I (Table II). F-II showed unusual
inhibitor susceptibility compared with F-I, though it retained basic
nature as a caspase. F-II was almost insusceptible at 1 mM concentration
of N-ethylmaleimide and iodoacetic acid, whereas more than 90% of
F-I activity was inhibited. Even at 0.1 M N-ethylmaleimide and
iodoacetic acid, µ30% of F-II activity was observed. When tetrapeptide
inhibitors Ac-YVAD-CHO and Ac-DEVD-CHO were used, F-I and
F-II showed different inhibition profiles as shown in Fig 3. The
activity of F-I was not inhibited by Ac-YVAD-CHO up to 10 µM,
but was inhibited by Ac-DEVD-CHO in a concentration-dependent
Figure 2. Elution profile of Superose 6 gel filtration chromatography
shows different molecular weights of F-I and F-II. Enzymatically active
fractions obtained from Mono Q ion-exchange chromatography were applied
to a SMART Superose 6 gel filtration column (0.32 cm330 cm). Caspase-like
activities were monitored by cleavage of Ac-YVAD-MCA and Ac-DEVD-
MCA. Molecular weights were determined to be 30 kDa for F-I (A) and
110 kDa for F-II (B).
Table I. Kinetic parameters for caspase-like enzymes from
epidermis
Km (µM) Ki (nM)
Ac-DEVD- Ac-YVAD- Ac-DEVD- Ac-YVAD-
MCA MCA CHO CHO
F-I 13.8 n.d. 0.0389 n.d.
F-II 402 1029 8190
Caspase-1a 14.3b 0.76b
Caspase-3a 9.7c ,1c
aIsolated from THP-1 cells.
bData from Thornberry et al (1992).
cData from Nicholson et al (1995).
manner. F-II was inhibited by both inhibitors to the similar extent;
however, inhibition was rather weak compared with F-I.
Purified caspases have an activity to cleave PARP Because
caspase-3 was identified as an enzyme responsible for PARP inactivation
during apoptosis, we examined PARP cleavage activity using purified
bovine PARP as a substrate. Western blot analysis (Fig 4) showed
cleavage product at 85 kDa after incubation with F-I, supporting the
hypothesis that F-I is a caspase-3-like protease. When F-II was
incubated with the purified PARP, it was also able to generate 85 kDa
fragment, showing that F-II shared a caspase-3-like property.
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Figure 3. Inhibition profiles of F-I and F-II by synthetic tetrapeptide
inhibitors demonstrate that F-I is specific to Ac-DEVD-CHO. F-I and
F-II were incubated with tetrapeptide aldehyde inhibitors and the residual
activities were measured. F-I was specifically inhibited by Ac-DEVD-CHO
but was not inhibited by Ac-YVAD-CHO up to 10 mM. On the other hand
F-II was inhibited by both inhibitors to a similar extent.
Figure 4. F-I and F-II have a cleavage activity on purified bovine PARP.
Purified bovine PARP was incubated with F-I and F-II for 30 min at 37°C.
After SDS-PAGE, reaction products were analyzed by western blotting using
anti-PARP antibody.
Table II. Effect of various protease inhibitors on F-I and F-II
Residual activity (%)
Inhibitor Concentration F-I F-II
PMSF 1 mM 100 98.5
SBTI 10 µg per ml 100 89.4
TLCK 1 mM 100 100
aprotinin 10 µg per ml 100 100
antipain 10 µg per ml 100 100
pepstatin 50 µg per ml 100 100
EDTA 5 mM 87.6 100
leupeptin 10 µg per ml 100 100
E-64 50 µg per ml 100 97.5
iodoacetic acid 1 mM 0 100
10 mM 0 89.9
100 mM 0.44 28.0
N-ethylmaleimide 1 mM 8.19 84.9
10 mM 3.60 64.9
100 mM 2.56 35.4
Ac-YVAD-CHO 10 µM 100 34.4
Ac-DEVD-CHO 10 µM 12.6 18.3
Figure 5. Optimum pH of F-I and F-II. The pH dependence of F-I and
F-II were measured at various pH valuess using Ac-DEVD-MCA as a substrate.
Buffers used were 25 mM sodium phosphate (pH 5.5–6.7) and 25 mM Tris-
HCl (pH 7.0–8.5). Both caspases were most active at pH 7.5.
Figure 6. Affinity labeling reveals that F-II is an oligomer of multiple
caspases. F-II from Superose 6 were incubated with biotin-YVAD-cmk for
30 min at room temperature and applied on 12.5% native-PAGE (lane 1) or
SDS-PAGE (lane 2) gel under nonreducing conditions. After transfer to a
polyvinylidenefluoride membrane, the enzyme-inhibitor complexes were stained
with horseradish peroxidase-conjugated streptavidin and visualized using ECL
detection system.
Optimum pH values The pH dependence of F-I and F-II was
measured at various pH values using Ac-DEVD-MCA as a substrate.
As shown in Fig 5, both fractions were most active at pH 7.5. F-II,
however, showed broader pH optimum. F-II showed more than 50%
activity even at pH 5.5 compared with that of F-I at pH 7.5, whereas
F-I showed sharp pH dependence.
F-II is an oligomer with multiple species These data suggest that
F-II is the most unusual type of caspase ever identified. For further
evaluation of F-II, affinity-labeled complex was analyzed by horseradish
peroxidase-conjugated streptavidin after incubation with large excess
of biotin-YVAD-cmk for 30 min. In native-PAGE, F-II-YVAD com-
plex was detected in a single band at high molecular weight region
(Fig 6, lane 1). On the other hand, SDS-PAGE did not demonstrate
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Figure 7. RT-PCR analysis shows that multiple caspase genes are expressed in cultured human keratinocytes. Expression of caspase-related genes were
analyzed by RT-PCR. mRNA were isolated from cultured human keratinocytes at 50%, 80%, confluent monolayer, and 2 d after confluency. Primers were
designed from the known sequences of seven members of human caspases. Caspase-1, 22, 23, 24, and 27 were expressed in cultured human keratinocytes.
any band at high molecular weight, but several bands were observed
in the 25–35 kDa range (Fig 6, lane 2). These results suggest that F-II
is a complex consisting of different species of caspase family members,
and the complex is dissociable in the presence of SDS.
Multiple caspase genes are expressed in human
keratinocytes We designed specific primer pairs for seven caspase
family members, caspase-1 to caspase-7, based on the published cDNA
sequences. As shown in Fig 7, mRNA of caspase-1 (310 bp), -2
(1080 bp), -3 (410 bp), -4 (285 bp), and -7 (917 bp) were detected in
cultured human keratinocytes at different stages. Interestingly, expres-
sion levels of each caspase showed significant difference. After the cells
reached confluency, expression of caspase-7 was no longer detectable.
Quantities of amplified cDNA of caspase-1, caspase-2, and caspase-3
were gradually decreased, whereas caspase-4 did not show significant
changes and maintained its expression level after the confluent con-
dition.
DISCUSSION
Although apoptosis-like phenomena are often found in human epi-
dermis, participation of caspases has not been reported to date. Thus,
it is important to purify and identify the epidermal caspases. This study
isolates caspase-like proteases from normal epidermis. Two distinct
types of caspase-like proteases (F-I and F-II) were obtained from
human cornified cell extract, which were iodoacetic acid and N-
ethylmaleimide-sensitive but E-64-insensitive cysteine proteases. This
kind of selective inhibitor susceptibility to general cysteine protease
inhibitors is a characteristic feature for caspases (Thornberry et al, 1992;
Nicholson et al, 1995); however, F-I and F-II showed considerably
different properties in terms of activity, molecular weight, substrate
specificity, and inhibitor susceptibility. Among human caspases, caspase-
3, caspase-6, and caspase-7 possess similar specificity to tetrapeptide
DEVD substrate and designated as caspase-3 subfamily (Duan et al,
1996). The low molecular weight fraction, F-I, showed almost identical
properties to those of the caspase-3 subfamily. F-I specifically hydrolyzed
Ac-DEVD-MCA and was inhibited by Ac-DEVD-CHO. F-I did not
show any effect on Ac-YVAD-MCA, and Ac-YVAD-CHO had no
effect on F-I activity. Molecular weight estimated by gel filtration is
identical to the heterodimeric complex of p20 and p10 (Thornberry
et al, 1992). The Km value of F-I (13.8 µM) is comparable with those
of 9.7 µM for caspase-3 from THP.1 cells (Nicholson et al, 1995),
13 µM of recombinant caspase-3, and 51 µM of recombinant caspase-
7 (Fernandes-Alnemri et al, 1995). The Ki value (0.0389 nM) is also
similar to that of caspase-3, which was lower than 1 nM (Nicholson
et al, 1995). These kinetic parameters strongly suggest that F-I is a
caspase-3-like protease. Proteolytic cleavage of PARP is a distinctive
phenomenon during apoptosis and it is induced by a protease resembling
ICE, but not by ICE itself (Lazebnik et al, 1994). Recent studies have
shown that protease resembling ICE is a member of the caspase-3
subfamily. Our results also revealed that F-I possessed a limited
proteolytic activity on PARP and generated a specific 85 kDa cleavage
product. Taken together, F-I is a caspase-3-like cysteine protease.
F-II, on the other hand, has distinct properties compared with other
caspases. F-II was not obtained when cornified cells were extracted in
the absence of CHAPS (data not shown), thus, the addition of CHAPS
is essential for the extraction of F-II. This result suggests that F-II is
associated with cell membrane or contains membrane-bound proteins.
Although F-II is also an E-64-insensitive cysteine protease, its properties
are quite different from other caspases. It hydrolyzed both YVAD and
DEVD tetrapeptide substrates with considerably lower affinity, and
showed unusually higher molecular weight. The Km values for Ac-
DEVD-MCA and Ac-YVAD-MCA were considerably higher than
9.7 µM for caspase-3 (Nicholson et al, 1995) and 14.3 µM for caspase-
1 (Thornberry et al, 1992). Taken together, these results suggest that
F-II is different in protease function from known caspases. These
unique properties of F-II might be ascribed to a formation of hetero-
oligomer consisting of different species of caspase family members.
Caspase-like proteases consist of p20 and p10 subunits to form active
heterodimer (Thornberry et al, 1992). X-ray crystallography revealed
that recombinant caspase-1 protein exists in the form of tetramer
consisting of two heterodimers (Walker et al, 1994; Wilson et al, 1994).
Because RT-PCR analysis revealed that five different types of caspases
are expressed in cultured human keratinocytes, and affinity labeling
proved association of several 30 kDa species to form oligomeric F-II,
it is reasonable to postulate that multiple species of caspase family
members associate each other and form hetero-oligomers. The decrease
in affinity to substrates and to inhibitors can be explained by the partial
denaturation during the extraction process or the involvement of
inactive precursor form (45 kDa) to form hetero-dimerization with
different species. Another possibility is a complex formation with
unidentified binding protein to regulate caspase activity.
A couple of evidences showed the hetero-oligomerization of caspases
could occur, as seen in caspase-3 and caspase-7 (Fernandes-Alnemri
et al, 1995), caspase-1 and caspase-4 (Gu et al, 1995). Recombinant
caspase-1 subunits are in reversible equilibrium to form oligomers
in vitro, showing different activity and stability (Talanian et al, 1996).
It also reported that C. elegance cell death factor Ced-3 can interact
with Ced-4 and Ced-9 (Chinnaiyan et al, 1997; Spector et al, 1997).
Recently, human Ced-4 homolog (Apaf-1) has been isolated from
cytosolic extract of HeLa cells (Zou et al, 1997). Apaf-1 forms a
complex with cytochrome c and caspase-9 (Li et al, 1997). These
observations suggest that it is quite possible to associate different caspase
family members to form oligomeric protease species like F-II in
this study.
RT-PCR analysis demonstrated that at least five caspase mRNA
were expressed in cultured human keratinocytes. Expression of caspase-
3 and caspase-7 supports the presence of caspase-3-like fraction, F-I,
in the cornified cell extract. Expression of multiple caspase family
members supports the oligomeric feature of F-II. In addition, our
results clearly showed that the production of caspases starts at very
early stages when cells are still in log phase proliferation. Although we
have no evidence that oligomerization is required for the induction of
keratinocyte apoptosis, oligomerization of multiple caspases as seen in
F-II seems to be a unique character.
The presence of two distinct fractions may represent an activation
process of a caspase cascade in epidermis. It has been shown that
caspase-3-like activity is gradually increased depending on the caspase-
1-like protease activity in Fas-mediated apoptosis (Enari et al, 1996).
This means that caspase-3 is activated downstream of caspase-1 in a
sequential caspase cascade. Our results suggest that a similar mechanism
may occur in terminal differentiation of keratinocytes. Because YVAD-
specific fraction was not extracted from cornified cells, activation of
caspase-3 (or caspase-3-like protease) may occur downstream of caspase-
1 (or caspase-1-like protease) in terminally differentiated keratinocytes.
Concerning the results of biochemical characterization, it might be
possible to postulate that F-I is an activated caspase-3-like protease
released from F-II, and F-II can be considered as a partially active
intermediate complex in the course of the activation process as observed
in the case of caspase-3 activation by Apaf complex (Li et al, 1997).
It is now evident that the terminal differentiation of keratinocytes
involves activation of caspases, in other words, apoptotic processes.
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Epidermal apoptosis, however, seems to be much more complicated
and likely to involve more factors to form the functional barrier against
the environment. Caspases extracted in this study may play important
roles in the regulation of epidermal apoptosis and thus for controlling
terminal differentiation.
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